Krystal Biotech (KRYS) Stock Chart & Stock Price History → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free KRYS Stock Alerts $166.83 +2.38 (+1.45%) (As of 05/21/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Krystal Biotech Stock Price Performance5 Day Performance+1.86%1 Month Performance+5.24%3 Month Performance+54.46%6 Month Performance+64.77%Year-To-Date Performance+34.48%1 Year Performance+73.67% Receive KRYS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. KRYS Stock Chart for Tuesday, May, 21, 2024 KRYS Chart by TradingView Krystal Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2024$164.45$166.83+1.45%$166.91$162.74179,149 shs$4.76 billion05/20/2024$164.10$164.45+0.21%$166.43$162.70185,227 shs$4.70 billion05/17/2024$163.78$164.10+0.20%$164.38$160.95180,033 shs$4.69 billion05/16/2024$163.19$163.78+0.36%$165.54$160.93159,467 shs$4.68 billion05/15/2024$159.47$163.19+2.33%$167.21$162.00271,077 shs$4.66 billion05/14/2024$154.82$159.47+3.00%$159.73$155.83141,354 shs$4.55 billion Get the Latest News and Ratings for KRYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/13/2024$154.76$154.82+0.04%$159.15$154.48192,160 shs$4.42 billion05/10/2024$158.74$154.76-2.50%$160.58$154.49186,317 shs$4.42 billion05/09/2024$157.68$158.74+0.67%$160.41$155.95197,304 shs$4.53 billion05/08/2024$161.76$157.68-2.52%$162.89$155.02244,959 shs$4.50 billion05/07/2024$156.94$161.76+3.07%$162.34$154.49359,034 shs$4.61 billion05/06/2024$161.10$156.94-2.58%$159.18$144.00800,468 shs$4.47 billion05/03/2024$160.23$161.10+0.54%$164.74$157.90453,060 shs$4.59 billion05/02/2024$159.67$160.23+0.35%$162.99$158.58229,071 shs$4.57 billion05/01/2024$153.12$159.67+4.28%$160.16$152.16411,585 shs$4.55 billion04/30/2024$157.99$153.12-3.08%$158.60$152.94221,376 shs$4.37 billion04/29/2024$156.88$157.99+0.71%$161.31$157.30196,281 shs$4.51 billion04/26/2024$155.68$156.88+0.77%$158.93$153.79165,898 shs$4.47 billion04/25/2024$159.05$155.68-2.12%$157.71$153.44242,413 shs$4.44 billion04/24/2024$162.04$159.05-1.85%$165.79$157.86237,973 shs$4.53 billion04/23/2024$157.25$162.04+3.05%$164.73$157.92223,159 shs$4.62 billion04/22/2024$158.53$157.25-0.81%$160.70$156.52341,796 shs$4.48 billion04/19/2024$163.97$158.53-3.32%$164.53$155.91341,337 shs$4.52 billion04/18/2024$169.64$163.97-3.34%$171.37$163.52281,100 shs$4.67 billion04/17/2024$170.09$169.64-0.26%$172.31$168.60148,515 shs$4.84 billion04/16/2024$169.75$170.09+0.20%$172.44$168.48200,430 shs$4.85 billion04/15/2024$173.62$169.75-2.23%$174.79$169.12281,252 shs$4.84 billion04/12/2024$179.94$173.62-3.51%$179.10$171.81263,078 shs$4.95 billion04/11/2024$175.70$179.94+2.41%$180.52$174.77197,006 shs$5.13 billion04/10/2024$179.77$175.70-2.26%$178.24$174.07244,999 shs$5.01 billion04/09/2024$180.42$179.77-0.36%$182.02$178.36254,775 shs$5.13 billion04/08/2024$180.02$180.42+0.22%$182.18$176.57336,539 shs$5.14 billion04/05/2024$178.48$180.02+0.86%$182.51$175.60229,473 shs$5.09 billion04/04/2024$177.87$178.48+0.34%$182.37$175.81301,266 shs$5.05 billion04/03/2024$176.91$177.87+0.54%$181.35$174.20231,338 shs$5.03 billion04/02/2024$176.07$176.91+0.48%$177.50$171.12192,979 shs$5.00 billion04/01/2024$177.93$176.07-1.05%$181.61$175.08365,529 shs$4.98 billion03/29/2024$177.93$177.93$180.24$175.92392,925 shs$5.03 billion03/28/2024$177.20$177.93+0.41%$180.12$175.99392,908 shs$5.03 billion03/27/2024$174.17$177.20+1.74%$180.13$173.09349,192 shs$5.01 billionWarren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 03/26/2024$169.46$174.17+2.78%$177.09$169.66259,446 shs$4.93 billion03/25/2024$167.29$169.46+1.30%$171.76$166.11268,136 shs$4.79 billion03/22/2024$169.80$167.29-1.48%$171.10$166.13207,344 shs$4.73 billion03/21/2024$171.33$169.80-0.89%$175.39$169.45255,836 shs$4.80 billion03/20/2024$167.00$171.33+2.59%$171.93$163.75219,832 shs$4.85 billion03/19/2024$168.53$167.00-0.91%$173.34$166.55288,592 shs$4.72 billion03/18/2024$172.98$168.53-2.57%$172.32$165.56387,455 shs$4.77 billion03/15/2024$171.84$172.98+0.66%$174.85$169.941.03 million shs$4.89 billion03/14/2024$179.35$171.84-4.19%$179.03$168.96531,577 shs$4.86 billion03/13/2024$178.95$179.35+0.22%$181.42$175.53464,681 shs$5.07 billion03/12/2024$170.39$178.95+5.02%$180.90$168.50563,646 shs$5.06 billion03/11/2024$171.84$170.39-0.84%$174.83$167.63637,401 shs$4.82 billion03/08/2024$169.48$171.84+1.39%$175.51$166.47552,601 shs$4.86 billion03/07/2024$174.36$169.48-2.80%$176.06$168.75254,442 shs$4.80 billion03/06/2024$170.84$174.36+2.06%$177.46$170.81418,855 shs$4.93 billion03/05/2024$159.95$170.84+6.81%$189.58$166.051.05 million shs$4.83 billion03/04/2024$167.82$159.95-4.69%$170.27$159.36334,672 shs$4.52 billion03/01/2024$159.47$167.82+5.24%$169.55$160.79402,824 shs$4.75 billion02/29/2024$163.08$159.47-2.21%$165.93$155.77491,735 shs$4.51 billion02/28/2024$170.15$163.08-4.16%$173.00$162.11646,916 shs$4.60 billion02/27/2024$157.00$170.15+8.38%$172.81$155.371.12 million shs$4.80 billion02/26/2024$111.33$157.00+41.02%$162.28$125.852.24 million shs$4.43 billion02/23/2024$111.96$111.33-0.56%$113.33$109.57521,399 shs$3.14 billion02/22/2024$108.01$111.96+3.66%$113.22$107.50275,034 shs$3.16 billion02/21/2024$111.64$108.01-3.25%$112.45$107.81324,656 shs$3.05 billion02/20/2024$113.57$111.64-1.70%$113.77$108.45251,825 shs$3.15 billion Related Companies: IMVT Stock Price Chart CRSP Stock Price Chart HALO Stock Price Chart IBRX Stock Price Chart SWTX Stock Price Chart IOVA Stock Price Chart RVMD Stock Price Chart DNLI Stock Price Chart IMCR Stock Price Chart TWST Stock Price Chart Receive KRYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KRYS) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.